- Home
- BBIO vs JOBY Comparison
BBIO vs JOBY Comparison
Compare BBIO & JOBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- JOBY
- Stock Information
- Founded
- BBIO 2015
- JOBY 2009
- Country
- BBIO United States
- JOBY United States
- Employees
- BBIO N/A
- JOBY N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- JOBY Aerospace
- Sector
- BBIO Health Care
- JOBY Consumer Discretionary
- Exchange
- BBIO Nasdaq
- JOBY Nasdaq
- Market Cap
- BBIO 8.0B
- JOBY 7.6B
- IPO Year
- BBIO 2019
- JOBY N/A
- Fundamental
- Price
- BBIO $45.12
- JOBY $10.50
- Analyst Decision
- BBIO Strong Buy
- JOBY Buy
- Analyst Count
- BBIO 14
- JOBY 6
- Target Price
- BBIO $58.85
- JOBY $9.33
- AVG Volume (30 Days)
- BBIO 3.3M
- JOBY 30.1M
- Earning Date
- BBIO 07-31-2025
- JOBY 08-06-2025
- Dividend Yield
- BBIO N/A
- JOBY N/A
- EPS Growth
- BBIO N/A
- JOBY N/A
- EPS
- BBIO N/A
- JOBY N/A
- Revenue
- BBIO $127,415,000.00
- JOBY $111,000.00
- Revenue This Year
- BBIO $102.05
- JOBY $4,769.85
- Revenue Next Year
- BBIO $54.69
- JOBY $1,170.96
- P/E Ratio
- BBIO N/A
- JOBY N/A
- Revenue Growth
- BBIO N/A
- JOBY N/A
- 52 Week Low
- BBIO $21.72
- JOBY $4.66
- 52 Week High
- BBIO $45.48
- JOBY $11.16
- Technical
- Relative Strength Index (RSI)
- BBIO 77.53
- JOBY 61.98
- Support Level
- BBIO $39.65
- JOBY $8.50
- Resistance Level
- BBIO $45.18
- JOBY $9.23
- Average True Range (ATR)
- BBIO 1.49
- JOBY 0.58
- MACD
- BBIO 0.54
- JOBY -0.03
- Stochastic Oscillator
- BBIO 99.13
- JOBY 68.52
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About JOBY Joby Aviation Inc.
Joby Aviation Inc is a transportation company developing an all-electric, vertical take-off and landing (eVTOL) air taxi for commercial passenger service. Its Joby eVTOL aircraft is designed to transport a pilot and up to four passengers or an expected payload of up to 1,000 pounds at speeds of up to 200 mph. The aircraft is optimized for urban routes, with a target range of up to 100 miles on a single charge. The company is also developing an app-based platform to build and operate an aerial ridesharing service powered by a network of eVTOL aircraft that it will manufacture and operate. It has one operating and reportable segment, namely flight services. Currently, the company generates all of its revenue from flight services provided to the Department of Defense in the United States.